The Bloodline with Blood Cancer United Podcast

Julie Larson, LCSW Simantinee Roy, Matt Hunt, Alfredo Martinez, and Casey Kang The cancer experience isn’t just physical—it’s deeply emotional. Join us for this special episode recorded onsite while filming our SHARE Project video series, exploring emotional well-being in cancer survivorship. Listen in as four blood cancer survivors share how their diagnoses impacted their mental health and what h...

Mary Wells In this episode, we speak with Mary Wells, who was diagnosed with primary myelofibrosis in 2018, a rare blood cancer that falls under the umbrella of myeloproliferative neoplasms (MPN). Mary walks us through her journey, from the side effects and emotional toll of cancer to finding the right treatment that allowed her to reclaim her life. Mary shares the ups and downs of watch-and-wait...

Lakshmi Nayak, MD Primary Central Nervous System Lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the brain, spinal cord, or eyes. In this episode, Dr. Lakshmi Nayak of Dana-Farber Cancer Institute, helps us better understand this uncommon type of lymphoma.  From early signs and symptoms to diagnosis, treatment options, and the latest clinical trials, Dr. Nayak breaks it a...

Sara Grisales Jaramillo, LMSW En este episodio, conocemos a Sara Grisales Jaramillo, trabajadora social, gerente de Insight y del Centro de Llamadas de Cancer Care . Únase a la conversación donde Sara nos identifica las disparidades en el tratamiento de cáncer, las comunidades más afectadas y les brinda consejos a los pacientes y sus cuidadores de cómo abogar por una mejor calidad de salud. ...

Trent Wang, MD Curious about CAR T-cell therapy? We went straight to the source for answers. In this episode, the LLS Patient Education team visited The University of Miami Sylvester Cancer Center to meet with Dr. Trent Wang. He answered some of the most frequently asked questions from our patients and caregivers about this innovative cancer treatment – from who’s eligible and what to expect...

Eytan Stein, MD Acute myeloid leukemia (AML) is one of the most aggressive blood cancers—but science is making real progress. In this episode, Dr. Eytan Stein of Memorial Sloan Kettering breaks down what makes AML so challenging to treat, how it’s classified, and the latest therapies changing the outlook for patients. From combination therapies and menin inhibitors to future research on CAR T-cell...

Join us as we speak with Ashlee and Michael Cramer, the mother-son duo behind the Michael and Mom Talk Cancer podcast. Diagnosed at 19 with a rare and aggressive type of lymphoma, Michael endured intense treatments while Ashlee became his full-time caregiver. Together, they turned their pain into purpose—creating a platform to support other young adults and caregivers navigating cancer. In this ep...

When it comes to cancer and nutrition, there’s a lot of misinformation out there. Can sugar fuel cancer? Should you cut out carbs? In this episode, we’re busting some of the biggest myths about cancer nutrition and breaking down what really matters when it comes to fueling your body during treatment and beyond. Join us as we chat with LLS Registered Dietitians, Margaret Martin and Heather Knutson,...

Cesar Rodriguez, MD In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss the evolving landscape of myeloma treatment. Groundbreaking innovations are bringing new hope to patients and caregivers. Dr. Rodriguez breaks down the latest advancements in immunotherapy, including CAR T-cell therapy and bispecific antibodies. Hear how researchers and phys...

Francine Foss, MD A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options.  In this episode, we talk to Dr. Francine Foss of Yale University to break down what CTCL is, how to manage side effects, and the latest advancements in treatment—including promising immunotherapies like CAR T-cell therapy and bispecific antibodi...

Bilal Abid, MD In this episode, we sit down with Dr. Bilal Abid from University of Texas Health Science Center in Houston to discuss how healthcare disparities have an effect on cancer care — especially when it comes to cutting-edge treatments such as stem cell transplantations and CAR T-cell therapy. We discuss how race, socioeconomic status, education, and geographic location can determine a pat...

Alison Loren, MD A stem cell transplant for blood cancer is just the beginning – what may come next for the patient can be a complex journey. In this episode, Dr. Alison Loren of the University of Pennsylvania discusses graft-vs-host disease (GVHD), a possible complication of transplantation – exploring the latest advancements in treatment and how patients and caregivers can navigate the cha...

William Shomali, MD Research continues to accelerate for myelodysplastic syndromes (MDS), giving hope to patients and their loved ones. In this episode, Dr. William Shomali of Stanford University dives into cutting-edge treatments for both low and high-risk MDS. Learn about the innovative therapies that are enhancing quality of life and explore the promising strides towards curative treatments. Do...

Mateo Mejia Saldarriaga, MD En este episodio conocemos al Dr. Mateo Mejia Saldarriaga de Weill Cornell Medicine, hospital NewYork-Presbyterian. Únase para aprender cómo los avances científicos han transformado el tratamiento de mieloma dándole lugar a mejores resultados y pronósticos para pacientes.  DESCARGAR TRANSCRIPCIÓN HAGA CLIC AQUI para participar en la encuesta del episodio. Mencionad...

Mousa Ghannam Join us as we speak to Mousa Ghannam, who was diagnosed with chronic myeloid leukemia (CML) at the age of 24. He shares his ups and downs over the past 20 years and how he has persevered to become the happy and healthy husband and father he is now.  Don’t miss this inspiring episode of a blood cancer survivor who chooses to bet on life and not cash in his chips. DOWNLOAD T...

Yasmin Karimi, MD Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients. DOWNLOAD TRAN...

Rashad Hayes, LMSW Join us for a powerful message of hope and perseverance after a cancer diagnosis. In this episode, Rashad Hayes shares his experience of being diagnosed with follicular lymphoma at 22 years old and how it motivated him to reevaluate his mindset and push forward. Now a social worker and motivational speaker, Rashad introduces his C.A.K.E. methodology, a unique approach to embraci...

Sara Grisales Jaramillo, LMSW Navigating the maze of cancer care can be overwhelming. Join us as Sara Grisales Jaramillo, LMSW, of CancerCare ® discusses the challenges patients face in accessing affordable treatment and strategies to improve cancer outcomes. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  CancerCare Navajo Nation: The First Ca...

Ambreen Maan, MSW, LSW Megan Gilman, MD Peter Drahms, RN, BSN, C. Robert Bennett, PhD, CPNP-AC Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. A diagnosis of cancer can present many challenges when it comes to relationships with others and the relationship you have with yourself. In this episode, we speak with experts about...

Brian Connell There are new Medicare changes starting in January 2025 that will benefit cancer patients.   LLS Vice President of Federal Affairs, Brian Connell, joins us again on The Bloodline to inform us about these new changes and how they will impact Medicare patients.       In this episode, you will learn about the key changes for Part D, the prescription drug plan for Med...

Please join us for this special episode live from CancerCon ® , a young adult cancer conference presented by Stupid Cancer ® . Following a cancer diagnosis and treatment, oncologists often become the default primary care for patients. Transitioning away from the oncologist to a primary care provider for general healthcare may be challenging at times for patients but may have tremendous benefits. I...

Mayur Narkhede, MD Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers.   However, there is a beacon of hope. Tune in to our latest episode, where we speak to Dr. Mayur Narkhede of the University of Alabama about groundbreaking research and innovative treatments for CLL. Discover the potential of CAR T-cell therapy, bispecific anti...

Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope! Join us as Dr. Eric Padron of Moffitt Cancer Center and Dr. Lee Greenberger of The Leukemia & Lymphoma Society unveil the groundbreaking new CMML Initiative, fueled by recent funding aimed at revolutionizing treatment....

David Bond, MD The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell therapy and bispecific antibodies, researchers are making strides toward curative treatments and enhancing patients’ quality of life. In this episode, we speak with Dr. David Bond from The Ohio State University about the latest developm...

Shernan Holtan, MD Paul Rothweiler Joe Grey Exercise, or simply moving the body, can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park Comprehensive Cancer Center and blood cancer survivors, Paul Rothweiler and Joe Grey, share about a clinical trial they developed to introduce a personalized strength training program to pa...